Clinical Trials List
2012-05-30 - 2013-12-31
Phase III
Terminated8
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- KUANG-YAO YANG Division of Thoracic Medicine
- WEI-JUIN SU Division of Thoracic Medicine
- 余文光 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chen Chia-Hung Division of General Internal Medicine
- 廖偉志 Division of General Internal Medicine
- Chih-Yen Tu Division of General Internal Medicine
- 梁信杰 Division of General Internal Medicine
- Chih-Ching Yen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 秦建弘 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
- 方文豐 Division of Thoracic Medicine
- 蘇茂昌 Division of Thoracic Medicine
- 梁深怡 Division of Thoracic Medicine
- 劉世豐 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 吳沼漧 Division of Thoracic Medicine
- 陳永哲 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳子卿 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 覃俊士 Division of Thoracic Medicine
- Ming -Cheng Chan Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- Wei- Chang Huang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shu-Min Lin Division of Thoracic Medicine
- Horng-Chyuan Lin Division of Thoracic Medicine
- Chun-Hua Wang Division of Thoracic Medicine
- 黃建達 Division of Thoracic Medicine
- 羅友倫 Division of Thoracic Medicine
- kang-Yun LEE Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
573 participants
